Du Juan
Academic / Other · 2 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | QL1706+Lenvatinib+AG Regimen as First-line Treatment for Advanced Metastatic Pancreatic Cancer Advance Pancreatic Cancer | Phase 2 | 2025-09-03 |
| Recruiting | NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus AG Combined With PD-1 Sequential Radiotherapy as F Locally Advanced Pancreatic Cancer | N/A | 2024-04-01 |